Tissue Factor Pathway Inhibitor Modulates Fibrin Deposition In The Brain In a Manner That Is Independent Of Thrombomodulin and Activated Protein C

被引：0
|
作者：
Maroney, Susan A.
Ellery, Paul E. R.
Martinez, Nicholas D.
Zogg, Mark
Gilbert, Gary E.
Weiler, Hartmut
Mast, Alan E.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2302.2302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2302
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ANTICOAGULANT ACTIONS OF RECOMBINANT THROMBOMODULIN AND ACTIVATED PROTEIN C AND THEIR NEUTRALIZATION BY FACTOR VIII INHIBITOR BYPASS ACTIVITY (FEIBA)
    Jeske, Walter
    Siddiqui, Fakiha
    Siddiqui, Zafar
    Hoppensteadt, Debra
    Tsuruta, Kazuhisa
    Fareed, Jawed
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E29 - E29
  • [22] Effects of high plasma lipoprotein (a) levels on tissue factor pathway inhibitor and the protein C pathway
    Nisio, MD
    Ten Wolde, M
    Meijers, JCM
    Buller, HR
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (09) : 2123 - 2125
  • [23] Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia
    Tchaikovski, Svetlana N.
    Thomassen, M. Christella L. G. D.
    Costa, Serban-Dan
    Peeters, Louis L. H.
    Rosing, Jan
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (05) : 914 - 921
  • [24] Thrombomodulin and tissue factor pathway inhibitor levels as risk factors in patients with essential hypertension
    Makris, TK
    Krespi, PG
    Anastasiadis, GP
    Dodouras, T
    Triposkiadis, P
    Hatzizaharias, AN
    Perrakis, A
    Kyriakidis, MK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 443A - 443A
  • [25] Pharmacological targeting of the thrombomodulin–activated protein C pathway mitigates radiation toxicity
    Hartmut Geiger
    Snehalata A Pawar
    Edward J Kerschen
    Kalpana J Nattamai
    Irene Hernandez
    Hai Po H Liang
    Jose Á Fernández
    Jose A Cancelas
    Marnie A Ryan
    Olga Kustikova
    Axel Schambach
    Qiang Fu
    Junru Wang
    Louis M Fink
    Karl-Uwe Petersen
    Daohong Zhou
    John H Griffin
    Christopher Baum
    Hartmut Weiler
    Martin Hauer-Jensen
    Nature Medicine, 2012, 18 : 1123 - 1129
  • [26] Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues
    Bajaj, MS
    Kuppuswamy, MN
    Manepalli, AN
    Bajaj, SP
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (03) : 1047 - 1052
  • [27] Protein S is a cofactor for tissue factor pathway inhibitor
    Rosing, J.
    Maurissen, L. F. A.
    Tchaikovski, S. N.
    Tans, G.
    Hackeng, T. M.
    THROMBOSIS RESEARCH, 2008, 122 : S60 - S63
  • [28] A novel degradation pathway of tissue factor pathway inhibitor: Incorporation into fibrin clot and degradation by thrombin
    Ohkura, N
    Enjyoji, K
    Kamikubo, Y
    Kato, H
    BLOOD, 1997, 90 (05) : 1883 - 1892
  • [29] Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α
    Thomassen, M. C. L. G. D.
    Heinzmann, A. C. A.
    Herfs, L.
    Hartmann, R.
    Dockal, M.
    Scheiflinger, F.
    Hackeng, T. M.
    Rosing, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (01) : 92 - 100
  • [30] FULL-LENGTH HUMAN TISSUE FACTOR PATHWAY INHIBITOR INHIBITS HUMAN ACTIVATED PROTEIN-C IN THE PRESENCE OF HEPARIN
    HAMAMOTO, T
    KISIEL, W
    THROMBOSIS RESEARCH, 1995, 80 (04) : 291 - 297
12345